GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Cyclically Adjusted PS Ratio

Chong Kun Dang Pharmaceutical (XKRX:185750) Cyclically Adjusted PS Ratio : 1.16 (As of Jun. 09, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Chong Kun Dang Pharmaceutical's current share price is ₩106700.00. Chong Kun Dang Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩91,638.30. Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio for today is 1.16.

The historical rank and industry rank for Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:185750' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.08   Med: 1.18   Max: 1.39
Current: 1.16

During the past years, Chong Kun Dang Pharmaceutical's highest Cyclically Adjusted PS Ratio was 1.39. The lowest was 1.08. And the median was 1.18.

XKRX:185750's Cyclically Adjusted PS Ratio is ranked better than
68.78% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs XKRX:185750: 1.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chong Kun Dang Pharmaceutical's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩28,455.784. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩91,638.30 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chong Kun Dang Pharmaceutical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Cyclically Adjusted PS Ratio Chart

Chong Kun Dang Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.45

Chong Kun Dang Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.45 1.20

Competitive Comparison of Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio falls into.



Chong Kun Dang Pharmaceutical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=106700.00/91638.3
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chong Kun Dang Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Chong Kun Dang Pharmaceutical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=28455.784/118.8477*118.8477
=28,455.784

Current CPI (Mar. 2024) = 118.8477.

Chong Kun Dang Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 10,349.219 99.353 12,379.907
201409 9,621.670 99.608 11,480.136
201412 10,666.394 99.098 12,792.149
201503 11,137.366 99.720 13,273.670
201506 10,582.187 100.050 12,570.401
201509 11,308.160 100.110 13,424.721
201512 11,737.918 100.220 13,919.622
201603 15,249.314 100.560 18,022.533
201606 15,551.787 100.790 18,338.070
201609 15,464.724 101.460 18,114.990
201612 16,600.567 101.560 19,426.341
201703 15,091.685 102.850 17,439.106
201706 15,193.570 102.610 17,597.903
201709 15,806.143 103.490 18,151.742
201712 17,556.309 102.990 20,259.510
201803 15,837.410 104.100 18,081.074
201806 17,172.277 104.130 19,599.401
201809 17,018.152 105.650 19,144.044
201812 23,730.397 104.350 27,027.342
201903 16,941.221 104.490 19,269.070
201906 19,299.207 104.880 21,869.435
201909 20,311.441 105.200 22,946.464
201912 26,654.660 105.120 30,135.512
202003 21,262.651 105.540 23,943.691
202006 22,763.862 104.870 25,797.965
202009 25,981.645 106.200 29,075.883
202012 30,093.381 105.765 33,815.682
202103 22,650.000 107.357 25,074.242
202106 23,831.176 107.579 26,327.545
202109 24,948.160 108.759 27,262.351
202112 32,781.199 109.676 35,522.411
202203 25,145.246 111.806 26,728.977
202206 27,042.907 114.083 28,172.409
202209 28,421.518 114.831 29,415.604
202212 29,777.837 115.200 30,720.671
202303 27,278.788 116.550 27,816.665
202306 31,030.071 117.140 31,482.463
202309 31,652.929 119.111 31,582.906
202312 39,924.919 118.848 39,924.919
202403 28,455.784 118.848 28,455.784

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chong Kun Dang Pharmaceutical  (XKRX:185750) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Chong Kun Dang Pharmaceutical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756
Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines